Beta Bionics
BBNX
13.36
+0.04
+0.30%
Beta Bionics
US · BBNX
#3406 by market cap
Listed 2025
13.36
+0.04
+0.30%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Leerink Partners Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $27Market Newswire · 2026/9/17
-
BofA Securities Maintains Beta Bionics(BBNX.US) With Hold Rating, Raises Target Price to $22Market Newswire · 2026/10/28
-
Rating change
Analysts' Opinions Are Mixed on These NA Stocks: Beta Bionics, Inc. (BBNX) and Pelthos Therapeutics (PTHS)TipRanks · 2026/9/15
-
Rating change
Piper Sandler Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $24Market Newswire · 2026/10/28
-
Barclays Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $30Market Newswire · 2026/10/30
-
Rating change
Lake Street Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $25Market Newswire · 2026/9/18
-
Rating change
Jefferies Initiates Beta Bionics(BBNX.US) With Buy Rating, Announces Target Price $30Market Newswire · 2026/10/12
-
Rating change
Truist Financial Maintains Beta Bionics(BBNX.US) With Buy RatingMarket Newswire · 2026/9/14
-
Rating change
Truist Financial Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $28Market Newswire · 2026/9/24
-
Rating change
Analysts Offer Insights on NA Companies: General Dynamics (GD), Alphabet Class A (GOOGL) and Beta Bionics, Inc. (BBNX)TipRanks · 2026/9/14
-
Wells Fargo Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $28Market Newswire · 2026/10/28
-
Rating change
Stifel Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $22Market Newswire · 2026/9/16
-
Barclays Initiates Beta Bionics(BBNX.US) With Buy Rating, Announces Target Price $30Market Newswire · 2026/10/7
-
A Quick Look at Today's Ratings for Beta Bionics(BBNX.US), With a Forecast Between $22 to $30Market Newswire · 2026/10/29
-
Rating change
Lake Street Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $25Market Newswire · 2026/9/22
-
Rating change
Analysts' Opinions Are Mixed on These NA Stocks: Douglas AG (OtherDOUDF) and Beta Bionics, Inc. (BBNX)TipRanks · 2026/9/18
-
Rating change
Analysts Offer Insights on NA Companies: Beta Bionics, Inc. (BBNX), Meta Platforms (META) and Turn Therapeutics Inc (TTRX)TipRanks · 2026/9/15
-
Rating change
Beta Bionics, Inc. (BBNX) Receives a Buy From Stifel NicolausTipRanks · 2026/9/16
-
Rating change
Wells Fargo Initiates Beta Bionics(BBNX.US) With Buy Rating, Announces Target Price $28Market Newswire · 2026/9/23
-
Rating change
A Quick Look at Today's Ratings for Beta Bionics(BBNX.US), With a Forecast Between $18 to $27Market Newswire · 2026/9/15
-
Rating change
William Blair Initiates Beta Bionics(BBNX.US) With Hold RatingMarket Newswire · 2026/8/21
-
Rating change
BofA Securities Maintains Beta Bionics(BBNX.US) With Hold Rating, Raises Target Price to $18Market Newswire · 2026/8/11
-
Beta Bionics, Inc. (BBNX) Q2 2025 Earnings Call Transcript SummaryMarket Newswire · 2026/10/13
-
Rating change
A Quick Look at Today's Ratings for Beta Bionics(BBNX.US), With a Forecast Between $15.5 to $30.4Market Newswire · 2026/7/31
-
Rating change
Analysts' Opinions Are Mixed on These NA Stocks: Lineage, Inc. (LINE), Beta Bionics, Inc. (BBNX) and Huron Consulting (HURN)TipRanks · 2026/9/14
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Beta Bionics discussion 0 comments